Kraig Biocraft Laboratories (KBLB) Share-based Compensation (2010 - 2019)

Kraig Biocraft Laboratories has disclosed Share-based Compensation across 9 years of filings, most recently posting -$19915.0 for Q2 2019.

• Share-based Compensation for Q2 2019 came in at -$19915.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$19915.0 (changed N/A YoY), and the FY2025 annual result was $834600.0, changed N/A from the prior year.
• Share-based Compensation came in at -$19915.0 for Q2 2019 at Kraig Biocraft Laboratories, down from $72575.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $842850.0 in Q2 2017 to a low of -$19915.0 in Q2 2019.
• The 5-year median for Share-based Compensation is $590335.0 (2015), against an average of $406748.0.
• Peak annual rise in Share-based Compensation reached 1306.22% in 2018, while the deepest fall reached 1306.22% in 2018.
• Kraig Biocraft Laboratories' Share-based Compensation stood at $590335.0 in 2015, then increased by 10.8% to $654074.0 in 2016, then gained by 28.86% to $842850.0 in 2017, then tumbled by 91.39% to $72575.0 in 2018, then sank by 127.44% to -$19915.0 in 2019.
• The last three Share-based Compensation figures came in at -$19915.0 (Q2 2019), $72575.0 (Q1 2018), and $842850.0 (Q2 2017), per Business Quant data.